UNLOCKING THE POTENTIAL OF SPERMINE: TARGETING HMOX1-INDUCED MITOPHAGY IN PROSTATE CANCER THERAPY

被引：0
|
作者：
Sun, Jingkai
Chiu, Peter Ka-Fung
Xie, Tingting
Teoh, Jeremy Yuen-Chun
Ho, Vincy Wing-Sze
Huang, Peng
Ng, Chi-Fai
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001008572.33286.63.12
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD09-12
引用
收藏
页码：E183 / E184
页数：2
相关论文
共 50 条
  • [31] Antibody targeting of claudin-1 as a potential colorectal cancer therapy
    Cherradi, S.
    Ayrolles-Torro, A.
    Vezzo-Vie, N.
    Gueguinou, N.
    Denis, V.
    Combes, E.
    Boissiere, F.
    Busson, M.
    Canterel-Thouennon, L.
    Mollevi, C.
    Pugniere, M.
    Bibeau, F.
    Ychou, M.
    Martineau, P.
    Gongora, C.
    Del Rio, M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [32] Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine
    Gunturu, Dilip R.
    Hassan, Mohammed
    Bedi, Deepa
    Datta, Pran
    Manne, Upender
    Samuel, Temesgen
    CURRENT ONCOLOGY, 2024, 31 (03) : 1195 - 1206
  • [33] Targeting the "Undruggable" Driver Protein, KRASG12D, as Potential Therapy in Prostate Cancer
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (04): : 365 - 366
  • [34] Dual targeting of Bcl-2 and VEGF: A potential strategy to improve therapy for prostate cancer
    Anai, Satoshi
    Sakamoto, Noboru
    Sakai, Yoshihisa
    Tanaka, Motoyoshi
    Porvasnik, Stacy
    Urbanek, Cydney
    Cao, Wengang
    Goodison, Steve
    Rosser, Charles J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (04) : 421 - 429
  • [35] BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
    Luk, Iris Sze Ue
    Shrestha, Raunak
    Xue, Hui
    Wang, Yuwei
    Zhang, Fang
    Lin, Dong
    Haegert, Anne
    Wu, Rebecca
    Dong, Xin
    Collins, Colin C.
    Zoubeidi, Amina
    Gleave, Martin E.
    Gout, Peter W.
    Wang, Yuzhuo
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1542 - 1551
  • [36] Targeting the prostate-specific membrane antigen for prostate cancer therapy
    Buehler, Patrick
    Wolf, Philipp
    Elsaesser-Beile, Ursula
    IMMUNOTHERAPY, 2009, 1 (03) : 471 - 481
  • [37] Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy
    Doxsee, Daniel W.
    Gout, Peter W.
    Kurita, Takeshi
    Lo, Maisie
    Buckley, Arthur R.
    Wang, Yuwei
    Xue, Hui
    Karp, Cristina M.
    Cutz, Jean-Claude
    Cunha, Gerald R.
    Wang, Yu-Zhuo
    PROSTATE, 2007, 67 (02): : 162 - 171
  • [38] The evolution of prostate cancer therapy: targeting the androgen receptor
    Aragon-Ching, Jeanny B.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [39] Targeting of adenoviral vectors for gene therapy of prostate cancer
    Bangma, CH
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 308 - 312
  • [40] Novel targeting of apoptosis pathways for prostate cancer therapy
    Garrison, JB
    Kyprianou, N
    CURRENT CANCER DRUG TARGETS, 2004, 4 (01) : 85 - 95
12345